TD Cowen has reduced its rating on Accenture, moving the stock from Buy to Hold while sharply lowering its price objective to $150 from $258. The brokerage said the investment case that once supported a more optimistic stance has deteriorated as revenue forecasts were revised downward and investor sentiment toward the consulting company has cooled.
Analysts at TD Cowen noted that a near-term rebound for Accenture has become harder to justify because earnings projections are slipping and the firm’s financial profile has not recovered as previously expected. The broker specifically trimmed its fiscal 2027 estimates for revenue, EBITDA and earnings per share in response to what it described as weaker-than-anticipated results and a contraction in recent bookings.
On top of booking weakness and slower organic growth, TD Cowen flagged broader macroeconomic uncertainty as a factor that reduces the visibility into a clear recovery path. The firm now models Accenture’s fiscal 2027 revenue growth at between 1% and 5% in constant currency terms, compared with the Wall Street aggregate expectation of 4.4% that the brokerage referenced. TD Cowen said elevated acquisition-related spending and increased leverage will likely weigh on profitability as the company moves toward 2027.
The analysts underscored an additional and distinct pressure point: artificial intelligence. Rapid developments in AI models, the brokerage wrote, are reshaping technology spending priorities and leave Accenture exposed to potentially negative AI-related headlines. TD Cowen also suggested that the company may require further organizational adjustments to accelerate workforce adaptation to the evolving AI environment.
Because of these combined forces - softer revenue trajectories, ongoing macro risks, booking contractions, and AI-related uncertainties - the firm concluded that near-term catalysts capable of driving a positive re-rating for the stock appear more remote than previously thought. As a result, TD Cowen lowered its valuation target and shifted to a neutral stance on the shares.
Clear summary
TD Cowen downgraded Accenture to Hold from Buy and cut its price target to $150 from $258, while trimming fiscal 2027 revenue, EBITDA and EPS estimates. The brokerage cited deteriorating investor sentiment, weaker bookings and revenue forecasts, macro uncertainty, acquisition spending and higher leverage as headwinds. The firm also emphasized exposure to negative AI-related news and the potential need for additional organizational changes.
Key points
- Rating change: TD Cowen moved Accenture from Buy to Hold and reduced its price target to $150 from $258.
- Lowered outlook: Fiscal 2027 revenue growth is modeled at 1% to 5% (constant currency) versus a Wall Street expectation of 4.4%; revenue, EBITDA and EPS estimates have been cut.
- Profitability pressures: The brokerage expects acquisition-related spending and higher leverage to weigh on margins and earnings through fiscal 2027.
Risks and uncertainties
- AI-related headlines: Rapid advances in AI models could trigger negative press or client spending shifts that would affect consulting revenues and technology-related projects.
- Macroeconomic uncertainty: Ongoing macro risks reduce visibility on demand for consulting services and may prolong the period before organic growth recovers.
- Bookings and acquisition effects: Recent bookings contraction and continued acquisition-related costs and leverage could keep near-term profitability below prior expectations.
These considerations leave TD Cowen on the sidelines for Accenture until clearer signs of durable revenue momentum and profitability recovery emerge.